V381 Cultures and endotoxin when clinically indicated
Written V0381 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.50(c)
- Standard: Monitoring, evaluation, and reporting requirements for the reuse of hemodialyzers and bloodlines. In addition to the requirements for hemodialyzer and bloodline reuse specified in paragraphs (a) and (b) of this section, the dialysis facility must adhere to the following: (2) When clinically indicated (for example, after adverse patient reactions), the facility must – (i) Obtain blood and dialysate cultures and endotoxin levels; and…
CMS's interpretive guidance
Interpretive Guidance § 494.50(c)(2)(i)
The facility must have a standardized procedure to ensure blood and dialysate cultures and dialysate endotoxin testing are obtained in the event of a patient reaction possibly related to dialyzer reprocessing and/or reuse.
https://middlemolecule.com/rulebook/tags/v381/